NASDAQ: IMUX
Immunic Inc Stock Ownership - Who owns Immunic?

Insider buying vs selling

Have Immunic Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when IMUX insiders and whales buy or sell their stock.

IMUX Shareholders

What type of owners hold Immunic Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Muneer A. Satter52.27%7,132,277$53.56MInsider
V. Cooperatieve Ua Lsp15.85%2,162,782$16.24MInsider
Vincent Ossipow10.05%1,371,494$10.30MInsider
Life Bioventure V. Sarl Global10.05%1,371,494$10.30MInsider
Fund Nv10.05%1,371,494$10.30MInsider
Andreas Muehler4.27%582,466$4.37MInsider
Terence E. Winters3.21%438,134$3.29MInsider
Daniel Vitt2.87%391,877$2.94MInsider
Manfred Groeppel2.04%278,830$2.09MInsider
Richard Alan Rudick1.69%230,375$1.73MInsider

1 of 3

IMUX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMUX0.05%99.95%
ENGN0.07%28.37%Net BuyingNet Buying
BDTX0.06%35.21%Net BuyingNet Buying
UNCY0.04%16.43%
VTVT0.00%100.00%

Immunic Stock Ownership FAQ

Who owns Immunic?

Immunic (NASDAQ: IMUX) is owned by 0.06% institutional shareholders, 116.70% Immunic insiders, and 0.00% retail investors. Muneer A. Satter is the largest individual Immunic shareholder, owning 7.13M shares representing 52.27% of the company. Muneer A. Satter's Immunic shares are currently valued at $53.56M.

If you're new to stock investing, here's how to buy Immunic stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.